先声药业(02096)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02096 先声药业

已收盘 07-06 16:08:32

12.030

+0.560

+4.88%

最高12.280	最低11.500	成交量1,526万
今开11.680	昨收11.470	日振幅6.80%
总市值308.93亿	流通市值308.93亿	总股本25.68亿
成交额1.83亿	换手率0.59%	流通股本25.68亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02096","market":"HK","secType":"STK","nameCN":"先声药业","latestPrice":12.03,"timestamp":1783325312004,"preClose":11.47,"halted":0,"volume":15258986,"delay":0,"changeRate":0.048823016564951936,"floatShares":2568000000,"shares":2568000000,"eps":0.6228856907572252,"marketStatus":"已收盘","change":0.56,"latestTime":"07-06 16:08:32","open":11.68,"high":12.28,"low":11.5,"amount":183191064,"amplitude":0.068003,"askPrice":12.03,"askSize":16000,"bidPrice":12.02,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":0.6228856907572252,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783387800000},"marketStatusCode":5,"adr":0,"listingDate":1603728000000,"exchange":"SEHK","adjPreClose":11.47,"dividendRate":0.017284,"openAndCloseTimeList":[[1783301400000,1783310400000],[1783314000000,1783324800000]],"volumeRatio":1.539251,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02096/wiki","defaultTab":"wiki","newsList":[{"id":"1100919489","title":"先声药业更新2026年6月股份变动月报表，股本减少2,749.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1100919489","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100919489?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:49","pubTimestamp":1783327743,"startTime":"0","endTime":"0","summary":"先声药业于2026年7月6日披露2026年6月股份变动月报表，公告显示，截至2026年6月30日，公司已发行股份由2,595,697,618股减少至2,568,198,618股。上述股本变化主要源于公司在2026年1月12日至5月22日期间购回的27,499,000股股份已于2026年6月8日注销，导致本月已发行股份数相应减少。公告指出，先声药业目前无其他股份期权或可换股票据发生变化，购回部分已完成注销，库存股份数量保持为零。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649449116","title":"港股异动 | 先声药业(02096.HK)最高涨近7% 公司强化自身免疫领域产品布局 机构指国内自免市场增长动能强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=2649449116","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649449116?lang=zh_cn&edition=full","pubTime":"2026-07-06 15:54","pubTimestamp":1783324478,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","02096","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648575107","title":"港股直击 | 创新药概念股继续走高，创新药支付改革加速，药企有望持续步入业绩收获期","url":"https://stock-news.laohu8.com/highlight/detail?id=2648575107","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648575107?lang=zh_cn&edition=full","pubTime":"2026-07-02 11:36","pubTimestamp":1782963369,"startTime":"0","endTime":"0","summary":"7月2日，创新药概念股继续走高，先声药业、三生制药涨超8%；信达生物涨超7%；康方生物涨近7%。消息面上，国家医保局公布2026年医保目录初审结果，共有557个药品通过医保目录初审，54个药品通过商保创新药目录初审，意味着“医保+商保”双目录谈判进入实质推进阶段。与此同时，预申报机制、8年价格保护等新机制同步落地，进一步完善创新药支付体系，为创新药商业化提供更加稳定的政策预期。","market":"hk","thumbnail":"https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462173.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0348767384.USD","LU0502904849.HKD","LU0348766576.USD","LU2476274720.SGD","LU0417516571.SGD","LU2488822045.USD","09926","LU0561508036.HKD","LU1969619763.USD","LU0348735423.USD","BK1583","LU0348783233.USD","LU2097828714.EUR","LU0634319403.HKD","LU2097828474.EUR","LU2476274308.USD","IE00BPRC5H50.USD","BK1589","BK1161","LU0348784397.USD","LU0455707207.USD","LU2097828805.USD","LU1961090484.USD","LU2097828557.USD","VXUS","LU2399975544.HKD","LU2778985437.USD","LU2097828631.EUR","01530","02096","LU0417516738.SGD","LU0348827113.USD","LU0417516902.SGD","BK1191","06978","HK0000165453.HKD","159992","BK1593","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU1720050803.USD","LU1794554557.SGD","01801","LU2242644610.SGD","BK4585","LU0540923850.HKD","LU0348825331.USD","BK4588","LU2328871848.SGD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648575835","title":"先声药业早盘涨超% 瑞银给予其目标价16.30港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2648575835","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648575835?lang=zh_cn&edition=full","pubTime":"2026-07-02 10:52","pubTimestamp":1782960720,"startTime":"0","endTime":"0","summary":"　　先声药业盘中涨近9%，截至发稿，股价上涨8.22%，现报10.66港元，成交额6320.55万港元。　　值得注意的是，瑞银最新研报重申给予先声药业“买入”评级，目标价为16.30港元。与此同时，华尔街分析师普遍给予先声药业“强烈买入”的一致评级，平均目标价为17.77港元。根据先声药业截至2025年12月31日的最新季度业绩，公司当季实现营收41.5亿港元，净利润7.404亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-02/doc-inifkqfu3634377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["EWH","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648464578","title":"港股异动 | 先声药业(02096)再涨近9% 瑞银等大行给予“买入”评级 公司业绩实现显著增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2648464578","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648464578?lang=zh_cn&edition=full","pubTime":"2026-07-02 09:42","pubTimestamp":1782956546,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，先声药业再涨近9%，截至发稿，涨7.92%，报10.63港元，成交额1503.86万港元。值得注意的是，瑞银最新研报重申给予先声药业“买入”评级，目标价为16.30港元。与此同时，华尔街分析师普遍给予先声药业“强烈买入”的一致评级，平均目标价为17.77港元。根据先声药业截至2025年12月31日的最新季度业绩，公司当季实现营收41.5亿港元，净利润7.404亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02096","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647589048","title":"瑞银重申先声药业(02096.HK)“买入”评级 目标价16.30港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647589048","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647589048?lang=zh_cn&edition=full","pubTime":"2026-06-30 11:23","pubTimestamp":1782789815,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","BK1583","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647380323","title":"先声药业午后涨近8% 近期与斯坦福大学医学院达成研究合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2647380323","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647380323?lang=zh_cn&edition=full","pubTime":"2026-06-29 13:27","pubTimestamp":1782710820,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　先声药业（02096）盘中涨近9%，截至发稿，股价上涨7.55%，现报9.97港元，成交额6278.85万港元。\n　　近日，斯坦福大学医学院与先声药业达成合作研究协议，为特发性肺纤维化（IPF）患者开发创新疗法。根据协议，先声药业将资助本项首创新分子（first-in-class）的探索性研究，成功后授权引进，并获产品100%全球权益。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-06-29/doc-inifacku5424157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02096","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647340801","title":"港股异动 | 先声药业(02096.HK)午前涨近9% 近期与斯坦福大学医学院达成研究合作协议 为IPF患者研发创新疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2647340801","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647340801?lang=zh_cn&edition=full","pubTime":"2026-06-29 11:29","pubTimestamp":1782703781,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02096","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643822932","title":"【券商聚焦】交银国际：医药行业上半年表现整体稳健 下半年内部分化或加大","url":"https://stock-news.laohu8.com/highlight/detail?id=2643822932","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643822932?lang=zh_cn&edition=full","pubTime":"2026-06-15 10:21","pubTimestamp":1781490116,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，医药行业在1H26表现整体稳健、但内部分化也较为明显。短期关注出海交易、业绩表现和利好政策落地。推荐高景气度赛道中、投资性价比较高的头部玩家，包括药明合联、凯莱英和康龙化成。2026年港股龙头收入和净利润增速有望稳定在双位数。板块复苏积极信号已经出现。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983754","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","LU0181495838.USD","01276","IE00BZ08YR35.GBP","LU0502904849.HKD","LU2097828631.EUR","06821","06990","01093","LU1242518857.USD","LU0140636845.USD","LU1960683339.HKD","LU1880383366.USD","LU2399975544.HKD","02273","LU0737861772.HKD","01530","06078","LU0819121731.USD","IE00B0JY6N72.USD","LU1226287875.USD","03329","LU0320764599.SGD","LU0456827905.SGD","03692","02596","SG9999002562.SGD","LU0051755006.USD","01951","09996","01177","09926","06996","01952","09966","02268","LU1688375341.USD","01801","02162","BK1191","BK1576","LU3063872942.SGD","01548","00013","06160","HK0000320264.USD","HK0000306685.HKD","03759","02269","LU0348827113.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642295887","title":"先声药业(02096)将于7月13日派发末期股息每股0.18元","url":"https://stock-news.laohu8.com/highlight/detail?id=2642295887","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642295887?lang=zh_cn&edition=full","pubTime":"2026-06-12 21:11","pubTimestamp":1781269907,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先声药业(02096)发布公告，该公司将于2026年7月13日派发末期股息每股0.18元人民币。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453986.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","02096","VIG","BK1583","BK1191","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642293703","title":"先声药业(02096)：SIM0689(PD-1/VEGF双特异性抗体)获国家药品监督管理局签发药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2642293703","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642293703?lang=zh_cn&edition=full","pubTime":"2026-06-12 21:02","pubTimestamp":1781269339,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先声药业(02096)发布公告，集团自主研发的靶向PD-1/ VEGF的双特异性抗体SIM0689已获得中国国家药品监督管理局(NMPA)签发的药物临床试验批准通知书，拟开展晚期实体瘤的临床试验。SIM0689是一种同时靶向程序性死亡受体1(PD-1)和血管内皮生长因子(VEGF)特殊表位的双特异性抗体，通过解除肿瘤细胞免疫抑制和抗血管生成，发挥强效的抗肿瘤活性。在多种人源化小鼠药效模型中，SIM0689在低剂量即展现出优异的抗肿瘤疗效，整体药效显著优于同类型分子，提示其在多种实体瘤中有广泛的应用前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453978.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1169590202.USD","02096","PD","BK1191","BK4023","BK1583","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134012338","title":"先声药业宣派末期股息每股0.18元人民币，派息日7月13日","url":"https://stock-news.laohu8.com/highlight/detail?id=1134012338","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134012338?lang=zh_cn&edition=full","pubTime":"2026-06-12 21:01","pubTimestamp":1781269312,"startTime":"0","endTime":"0","summary":"先声药业于2026年6月12日发布更新公告，明确截至2025年12月31日止年度的末期普通股息分派方案。公司宣派末期股息每股0.18元人民币，并以港元作为预设派发货币，按中国人民银行公布的汇率1人民币兑1.1496港元折算，折合每股派息0.2069港元。根据公告，此次派息的除净日定为2026年6月17日。为符合获取股息分派资格，股东须在2026年6月18日下午4时30分前递交股份过户文件。股息最终派发日为2026年7月13日。本次股息不涉及代扣代缴所得税。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"先声药业宣派末期股息每股0.18元人民币，派息日7月13日","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105597894","title":"先声药业SIM0689获国家药监局临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1105597894","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105597894?lang=zh_cn&edition=full","pubTime":"2026-06-12 21:01","pubTimestamp":1781269283,"startTime":"0","endTime":"0","summary":"先声药业宣布，其研发的创新药物SIM0689已正式获得中国国家药品监督管理局的临床试验批准。此项批准标志着该药物在中国本土的临床开发进程迈出了关键一步，为其后续的临床研究提供了法规基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130542183","title":"先声药业宣派末期股息每股0.18元，7月13日前后派发","url":"https://stock-news.laohu8.com/highlight/detail?id=1130542183","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130542183?lang=zh_cn&edition=full","pubTime":"2026-06-12 20:56","pubTimestamp":1781268981,"startTime":"0","endTime":"0","summary":"先声药业在2026年6月12日举行的股东周年大会上，通过决议宣派截至2025年12月31日止年度的末期股息，每股人民币0.18元。股息将以港元派付，按中国人民银行公布的股东周年大会日期前5个营业日人民币兑港元平均汇率中间价换算，折合每股0.2069港元。据此推算，除净日为2026年6月18日。末期股息预计将于2026年7月13日（星期一）或之前，派付予6月24日名列公司股东名册的股东。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"先声药业宣派末期股息每股0.18元，7月13日前后派发","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188726205","title":"先声药业携手斯坦福医学院 共研特发性肺纤维化创新疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1188726205","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188726205?lang=zh_cn&edition=full","pubTime":"2026-06-12 15:00","pubTimestamp":1781247616,"startTime":"0","endTime":"0","summary":"先声药业与斯坦福医学院达成一项研究合作协议，双方将共同致力于开发针对特发性肺纤维化患者的创新疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642108254","title":"港股异动 | 先声药业(02096)午后涨超3% 近日与普祺医药就普美昔替尼凝胶订立独家推广服务协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2642108254","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642108254?lang=zh_cn&edition=full","pubTime":"2026-06-10 13:39","pubTimestamp":1781069998,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，先声药业(02096)午后涨超3%，截至发稿，涨3.03%，报9.87港元，成交额4009.82万港元。消息面上，近日，先声药业发布公告，本集团与北京普祺医药科技股份有限公司(普祺医药)就普美昔替尼凝胶订立独家推广服务协议(该协议)。根据该协议，本集团将获得普美昔替尼凝胶在中国内地、香港及澳门所有皮肤病领域适应症的独家推广权益。目前，普美昔替尼凝胶成人与青少年特应性皮炎(AD)适应症新药上市申请(NDA)已获国家药品监督管理局药品审评中心(CDE)受理。本次合作将进一步强化本集团在自身免疫领域的产品布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02096","BK1583","BK1191","159938","BK4585","09939","BK1515","VXUS","BK1574","BK4588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103670289","title":"先声药业回购2749.90万股，涉资约3.12亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1103670289","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103670289?lang=zh_cn&edition=full","pubTime":"2026-06-08 20:08","pubTimestamp":1780920524,"startTime":"0","endTime":"0","summary":"先声药业集团有限公司于2026年6月8日公告，截至当日，公司已完成多笔股份购回，合计回购股份数量约2749.90万股，占回购前已发行股份总数约1.06%。相关股份购回价格范围每股约为10.4901港元至11.8259港元，共计耗资约3.12亿港元。公告显示，本次回购股份分别于2026年1月12日至5月22日期间多次进行，并已于2025年6月8日注销。回购完成后，公司已发行股本由原先的25.95697618亿股变更至25.68198618亿股，库藏股数保持为零。此公告由执行董事及联席公司秘书万玉山签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"先声药业回购2749.90万股，涉资约3.12亿港元","news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641328481","title":"先声药业(02096)6月8日注销2749.9万股已回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2641328481","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641328481?lang=zh_cn&edition=full","pubTime":"2026-06-08 19:56","pubTimestamp":1780919779,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先声药业(02096)公布，2026年6月8日注销2749.9万股已回购股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451599.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1191","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112668284","title":"先声药业5月股份变动月报：股本维持不变，购回股份尚未注销","url":"https://stock-news.laohu8.com/highlight/detail?id=1112668284","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112668284?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:36","pubTimestamp":1780475815,"startTime":"0","endTime":"0","summary":"2026年6月3日，先声药业集团有限公司发布截至2026年5月31日的证券变动月报表。本月公告主要披露公司已发行股本结构、股份买卖及潜在发行安排等内容。根据公告，先声药业当前已发行的普通股股数为2,595,697,618股，较上月底的2,595,697,618股无变化。库存股份数目维持为0股。先声药业于2023年6月15日修订并重列的受限制股份单位计划下，截至5月31日仍有235,201,361股可于日后发行。公司声明将持续遵守香港联交所《上市规则》和适用法律法规的相关规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640922332","title":"先声药业与普祺医药达成合作；和仁科技终止筹划控制权变更事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2640922332","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640922332?lang=zh_cn&edition=full","pubTime":"2026-06-03 08:02","pubTimestamp":1780444935,"startTime":"0","endTime":"0","summary":"政策动向开展消化介入类医用耗材产品信息集中维护国家组织高值医用耗材联合采购办公室发布《关于开展消化介入类医用耗材产品信息集中维护工作的通知》显示，按照工作安排，将于2026年6月1日起开展消化介入类医用耗材产品信息集中维护工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606033758181427.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606033758181427.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK1161","BK1574","BK0231","BK1583","159938","09939","BK0146","BK1515","300550","02096"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.simcere.com","stockEarnings":[{"period":"1week","weight":0.2373},{"period":"1month","weight":0.1928},{"period":"3month","weight":-0.14},{"period":"6month","weight":-0.0073},{"period":"1year","weight":-0.0005},{"period":"ytd","weight":-0.0214}],"compareEarnings":[{"period":"1week","weight":0.0299},{"period":"1month","weight":-0.0891},{"period":"3month","weight":-0.0703},{"period":"6month","weight":-0.1135},{"period":"1year","weight":-0.0299},{"period":"ytd","weight":-0.089}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"先声药业集团有限公司是一家从事药品的研发、生产和销售的公司。该公司的主要产品为仿制药，包括用于中枢神经系统疾病的产品必存、用于肿瘤疾病的产品捷百舒和捷佰立、以及用于自身免疫疾病的产品英太青。该公司还从事生产创新药，比如用于肿瘤疾病的恩度。该公司还从事为医疗机构销售的第三方药品提供推广服务。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.09318},{"month":2,"riseRate":0.666667,"avgChangeRate":0.070754},{"month":3,"riseRate":0.5,"avgChangeRate":-0.014037},{"month":4,"riseRate":0.5,"avgChangeRate":-0.003707},{"month":5,"riseRate":0.666667,"avgChangeRate":0.105952},{"month":6,"riseRate":0.666667,"avgChangeRate":0.032044},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.015992},{"month":8,"riseRate":0.4,"avgChangeRate":-0.051305},{"month":9,"riseRate":0.4,"avgChangeRate":-0.032404},{"month":10,"riseRate":0.8,"avgChangeRate":0.108743},{"month":11,"riseRate":0.666667,"avgChangeRate":0.044296},{"month":12,"riseRate":0.5,"avgChangeRate":0.000556}],"exchange":"SEHK","name":"先声药业","nameEN":"SIMCERE PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"先声药业(02096)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供先声药业(02096)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"先声药业,02096,先声药业股票,先声药业股票老虎,先声药业股票老虎国际,先声药业行情,先声药业股票行情,先声药业股价,先声药业股市,先声药业股票价格,先声药业股票交易,先声药业股票购买,先声药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"先声药业(02096)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供先声药业(02096)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}